Related Experiment Video
Updated: Feb 25, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Identification of novel genetic etiology and key molecular pathways for seminoma via network-based studies
Yuanlei Chen1, Chao Qi2, Liqun Xia1
1Department of Urology and Chawnshang Chang Liver Cancer Center, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.
Abstract:
Seminoma is the most common testicular malignant germ cell tumor which severely threaten male reproductive health. However, the pathogenesis and progression mechanisms are still unclear and little research is carried out to uncover the mechanism of this cancer. To identify gene signatures that are expected to converge on particular molecular pathways may drive the development of the core cancer characteristics in seminoma. We downloaded the gene expression profiles GSE18155 from GEO database and obtained the differentially expressed genes (DEGs). Then, we performed Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) enrichment analyses via DAVID. In total, 3,502 DEGs were identified, including 1,563 upregulated genes and 1,939 downregulated genes. The top 10 hub genes, Ubc, Ubb, Mapk8, Ar, Pten, Cdk2, Cdk4, Rac1, Top2a and Cdkn1a were identified from the protein-protein interaction (PPI) network which was constructed by Cytoscape. Sub-networks analyzed by MCODE plugin revealed these genes were involved in significant molecular pathways, including ERBB2 signaling pathway, pathways in cancer, PI3K‑AKT signaling pathway and cell cycle. Finally, validation of hub genes was checked via reverse transcription-polymerase chain reaction (RT-PCR) assay and immunohistochemistry (IHC). In conclusion, our study revealed that the identified hub genes increased the understanding of genetic etiology and molecular mechanisms underlying the development of seminoma, in return, they could be used as potential diagnostic biomarkers and therapeutic molecular targets for seminoma.
Insights
This study identifies key genes in seminoma, a common testicular cancer. These identified hub genes offer potential for new diagnostic biomarkers and therapeutic targets for seminoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Seminoma is the most frequent testicular malignant germ cell tumor, posing a significant threat to male reproductive health.
- The precise pathogenesis and progression mechanisms of seminoma remain largely unelucidated, with limited research focused on its underlying molecular mechanisms.
Purpose of the Study:
- To identify gene signatures converging on molecular pathways driving core cancer characteristics in seminoma.
- To uncover potential diagnostic biomarkers and therapeutic targets for seminoma through gene expression analysis.
Main Methods:
- Downloaded gene expression profiles (GSE18155) from the GEO database to identify differentially expressed genes (DEGs).
- Performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses using DAVID.
- Constructed a protein-protein interaction (PPI) network with Cytoscape to identify top 10 hub genes and analyzed subnetworks using the MCODE plugin.
Main Results:
- Identified 3,502 DEGs, comprising 1,563 upregulated and 1,939 downregulated genes.
- The top 10 hub genes identified include Ubc, Ubb, Mapk8, Ar, Pten, Cdk2, Cdk4, Rac1, Top2a, and Cdkn1a.
- Hub genes are implicated in significant molecular pathways such as ERBB2 signaling, pathways in cancer, PI3K-AKT signaling, and the cell cycle.
Conclusions:
- The identified hub genes enhance the understanding of the genetic etiology and molecular mechanisms in seminoma development.
- These hub genes represent promising candidates for diagnostic biomarkers and therapeutic molecular targets for seminoma.

